The HPRA advises healthcare professionals not to retain printed versions of Summary of Product Characteristics (SPC) documents. As these documents are subject to frequent content updates, including changes to safety and dose related information, we recommend that you visit our website as necessary to access the most up-to-date versions.If you have any queries about the SPCs on our website then please e-mail vetinfo@hpra.ie


Canergy 100 mg tablets for dogs



Le Vet Beheer B.V.VPA10475/016/001

Main Information

Trade NameCanergy 100 mg tablets for dogs
Active SubstancesPropentofylline
Dosage FormTablet
Licence HolderLe Vet Beheer B.V.
License Holder AddressWilgenweg 7
3421 TV Oudewater
Netherlands
Licence NumberVPA10475/016/001

Group Information

ATC CodeQC04AD90 propentofylline
Therapeutic ClassCardiovascular
SpeciesDogs

Status

License statusAuthorised
Licence Issued29/05/2015
Legal StatusPOM: Prescription Only Medicine as defined in relevant national legislation

Documents

Summary of Product Characteristics *PDF Version
Package LeafletNo document available
Public Assessment ReportNo document available
VariationsPDF Version

* The PDF document, together with the national-specific product information on this page, constitute the authorised SPC
« Back